Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?
Nefize Yalin, Allan H Young Centre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and Neuroscience, London, UKCorrespondence: Allan H YoungCentre for Affective Disorders, Department of Psychological Medicine, Institute of Psychiatry, Psychology and...
Guardado en:
Autores principales: | Yalin N, Young AH |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/d1f8190368fe49da9b93c2113314b505 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight
por: Findling RL, et al.
Publicado: (2018) -
Atypical depression: current perspectives
por: Łojko D, et al.
Publicado: (2017) -
Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis
por: Ueda S, et al.
Publicado: (2016) -
Treatment response in relation to subthreshold bipolarity in patients with major depressive disorder receiving antidepressant monotherapy: a post hoc data analysis (KOMDD study)
por: Park YM, et al.
Publicado: (2016) -
Effect of medication therapy combined with transcranial direct current stimulation on depression and response inhibition of patients with bipolar disorder type I: a clinical trial
por: Parnaz Mardani, et al.
Publicado: (2021)